Tyrosine Protein Kinase Fyn Market Analysis | 2021-2026

Tyrosine Protein Kinase Fyn Market Analysis | 2021-2026

Tyrosine Protein Kinase Fyn Market Analysis | 2021-2026
Report code - SRHL240 Delivery - 2 Weeks
Tyrosine Protein Kinase Fyn Market Size, Share, Trend, Forecast, Competitive Analysis, and See more...

"The Tyrosine Protein Kinase Fyn Market is expected to grow at a healthy CAGR during the forecast period".

Market Dynamics

Introduction

Tyrosine kinase is defined as an enzyme that can transfer a phosphate group from adenosine triphosphate (ATP) to tyrosine residues of specific proteins inside a cell. Tyrosine kinases play a crucial role in many biological processes such as cell adhesion, integrin-mediated signaling, regulation of cell growth and survival, immune response, and cell motility among others.

Market Drivers

The growth of the tyrosine-protein kinase Fyn market is primarily driven by an increasing number of people suffering from cancer across geographies.

  • Cancer has become the leading cause of death worldwide.
  • According to the International Agency for Research on Cancer, in 2018, around 18.1 million new cases of cancer were diagnosed globally, and this number is likely to increase to around 29.5 million by end of 2040.
  • Thus, increasing cancer cases is likely to propel market growth at a significant rate during the review.
  • Additionally, ongoing research to treat Alzheimer's disease using kinase inhibitors is likely to create lucrative opportunities for the market players.

COVID-19 Impact

The COVID-19 outbreak did affect the growth of the Tyrosine-protein kinase Fyn market as many healthcare services were postponed due to a rapid surge in COVID-19 cases and a lack of skilled healthcare professionals.

Only essential medicals services were allowed amid pandemics and thus, postponement of therapeutic medications affected the market growth for a short period of time.

Segments Analysis

Segmentations

List of Sub-Segments

Dominant and Fastest-Growing Segments

Application-Type Analysis

Alzheimer's Disease, Alcohol Addiction, Breast Cancer, Cancer Pain, Others

The Alzheimer's disease segment is projected to register healthy growth during the forecast period.

Regional Analysis

North America, Europe, Asia-Pacific, and Rest of the World

North America accounted for the largest market share in 2020.

 

By Application Type

“The Alzheimer’s disease segment is anticipated to show strong growth during the forecast period”.

  • The market has been segmented into Alzheimer’s disease, alcohol addiction, breast cancer, cancer pain, and others.
  • The cancer pain segment accounted for the largest market share in 2020 owing to the increasing number of people suffering from cancer disease.
  • The Alzheimer's disease segment is projected to register healthy growth during the review period.

Regional Analysis

“North America led the market share in 2020, with the Asia-Pacific region anticipated to grow at a robust CAGR during the forecast period”.

  • The market is broken down geographically into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
  • Geographically, the market in North America accounted for the largest market share of more than 30% in 2020.
  • The market growth can be attributed to presence of large number of people suffering from cancer and advancement in healthcare solutions.
  • In US, around 18 lakh new cancer cases were diagnosed.
  • The market in Asia-Pacific is expected to increase at a healthy CAGR during the forecast period on account of increasing demand for advanced healthcare solutions to treat cancer and other diseases.

Want to know which region offers the best growth opportunities? Register Here

Key Players

The following are the key players in the Tyrosine Protein Kinase Fyn Market (arranged alphabetically)

  • AB Science SA (France)
  • AstraZeneca Plc (UK)
  • BioLegend, Inc. (The U.S)
  • Biocompare, Inc. (The U.S)
  • Bristol-Myers Squibb Co (The U.S)
  • Merck KGaA (Germany)
  • Takara Bio Inc. (Japan).
  • Thermo Fisher Scientific (The U.S)
  • ValiRx Plc (UK)
  • Zen-Bio Inc (The U.S)

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Key questions this report answers

Relevant contents in the report

How big is the sales opportunity?

In-depth Analysis of Tyrosine Protein Kinase Fyn Market

How lucrative is the future?

The market forecast and trend data and emerging trends

Which regions offer the best sales opportunities?

Global, regional, and country-level historical data and forecasts

Which are the most attractive market segments?

Market segment analysis and Forecast

Which are the top players and their market positioning?

Competitive landscape analysis, Market share analysis

How complex is the business environment?

Porter’s five forces analysis, PEST analysis, Life cycle analysis

What are the factors affecting the market?

Drivers & challenges

Will I get the information on my specific requirement?

10% free customization

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

  • Detailed profiling of additional market players (up to three players)
  • SWOT analysis of key players (up to three players)

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research:

Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

Frequently Asked Questions (FAQs)

Tyrosine kinase is defined as an enzyme that can transfer a phosphate group from adenosine triphosphate (ATP) to tyrosine residues of specific proteins inside a cell. Tyrosine kinases play a crucial role in many biological processes such as cell adhesion, integrin-mediated signaling, regulation of cell growth and survival, immune response, and cell motility among others.

Increasing number of people suffering from cancer across geographies, increasing cancer cases, ongoing research to treat Alzheimer's disease using kinase inhibitors are the factors driving the growth of tyrosine protein kinase fyn market.

North America accounted for the largest share of tyrosine protein kinase fyn market in 2020.

The cancer pain segment accounted for the largest share of tyrosine protein kinase fyn market in 2020.

AB Science SA (France), Bristol-Myers Squibb Co (The U.S), ValiRx Plc (UK), AstraZeneca Plc (UK), Zen-Bio Inc (The U.S), Merck KGaA (Germany), Biocompare, Inc. (The U.S), BioLegend, Inc. (The U.S), Thermo Fisher Scientific (The U.S) and Takara Bio Inc. (Japan) are among the key players in the tyrosine protein kinase fyn market.

The market is studied from 2016-2026.